Thymoglobulin® Pharmacokinetics in Patients Undergoing Hematopoietic Stem Cell Transplantation

Inclusion Criteria

• •Patient receiving Thymoglobulin therapy as part of a first HSCT
• •Age ≥ 2 years
• •Lansky or karnofsky score ≥ 50%.
• •Enrolled in a social security plan
• •Patient 18 years of age or older who is informed and has consented to participate in the study or minor patient whose parents/guardians have been informed and have given consent for the minor patient to participate in the study
• •Female patients of childbearing potential must have an effective method of contraception (a pregnancy test will also be performed at inclusion).